Drug Shortage Report for TEVA-DILTIAZEM XC
Report ID | 199199 |
Drug Identification Number | 02429330 |
Brand name | TEVA-DILTIAZEM XC |
Common or Proper name | TEVA-DILTIAZEM XC |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 240MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-07-19 |
Estimated end date | 2023-12-10 |
Actual end date | 2023-12-13 |
Shortage status | Resolved |
Updated date | 2023-12-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2023-12-14 | French | Compare |
v16 | 2023-12-14 | English | Compare |
v15 | 2023-11-30 | French | Compare |
v14 | 2023-11-30 | English | Compare |
v13 | 2023-11-09 | French | Compare |
v12 | 2023-11-09 | English | Compare |
v11 | 2023-10-19 | French | Compare |
v10 | 2023-10-19 | English | Compare |
v9 | 2023-10-12 | French | Compare |
v8 | 2023-10-12 | English | Compare |
v7 | 2023-10-04 | French | Compare |
v6 | 2023-10-04 | English | Compare |
v5 | 2023-07-21 | French | Compare |
v4 | 2023-07-21 | English | Compare |
v3 | 2023-07-20 | English | Compare |
v2 | 2023-07-19 | French | Compare |
v1 | 2023-07-19 | English | Compare |
Showing 1 to 17 of 17